Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-05-23 Purchase | 2023-05-25 4:05 pm | Prelude Therapeutics Inc | PRLD | Chardonnet Laurent Chief Financial Officer | 5,000 | $5.5 | $27,500 | 42,165 (Direct) | View |
| 2022-12-08 Purchase | 2022-12-12 09:13 am | Prelude Therapeutics Inc | PRLD | Chardonnet Laurent Chief Financial Officer | 10,000 | $4.76 | $47,600 | 35,873 (Direct) | View |
| 2022-06-01 Purchase | 2022-06-01 4:31 pm | Prelude Therapeutics Inc | PRLD | Chardonnet Laurent Chief Financial Officer | 10,000 | $4.23 | $42,300 | 24,500 (Direct) | View |
| 2020-01-31 Purchase | 2020-01-31 8:44 pm | Axcella Health Inc. | AXLA | Chardonnet Laurent Chief Financial Officer | 3,000 | $4.94 | $14,820 | 3,665 (Direct) | View |
| 2020-01-24 Purchase | 2020-01-28 6:39 pm | Axcella Health Inc. | AXLA | Chardonnet Laurent Chief Financial Officer | 665 | $4.9306 | $3,279 | 665 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-01 Option Award | 2024-03-04 6:04 pm | N/A 2034-02-28 | Prelude Therapeutics Inc | PRLD | Chardonnet Laurent Chief Financial Officer | 150,000 | $0 | 150,000 (Direct) | View |
| 2023-02-07 Option Award | 2023-02-09 4:07 pm | N/A 2033-02-06 | Prelude Therapeutics Inc | PRLD | Chardonnet Laurent Chief Financial Officer | 135,000 | $0 | 135,000 (Direct) | View |
| 2022-12-21 Option Award | 2022-12-22 4:05 pm | N/A 2032-12-20 | Prelude Therapeutics Inc | PRLD | Chardonnet Laurent Chief Financial Officer | 75,000 | $0 | 75,000 (Direct) | View |
| 2022-03-21 Option Award | 2022-03-22 6:01 pm | N/A N/A | Prelude Therapeutics Inc | PRLD | Chardonnet Laurent Chief Financial Officer | 6,500 | $7.51 | 14,500 (Direct) | View |
| 2022-02-15 Option Award | 2022-02-17 7:11 pm | N/A 2032-02-14 | Prelude Therapeutics Inc | PRLD | Chardonnet Laurent Chief Financial Officer | 90,000 | $0 | 90,000 (Direct) | View |
| 2021-12-13 Option Award | 2021-12-14 5:37 pm | N/A N/A | Prelude Therapeutics Inc | PRLD | Chardonnet Laurent Chief Financial Officer | 5,000 | $12.28 | 8,000 (Direct) | View |
| 2021-11-29 Option Award | 2021-12-01 6:00 pm | N/A 2031-11-28 | Prelude Therapeutics Inc | PRLD | Chardonnet Laurent Chief Financial Officer | 180,000 | $0 | 180,000 (Direct) | View |
Ownership | 2021-12-01 5:56 pm | N/A N/A | Prelude Therapeutics Inc | PRLD | Chardonnet Laurent Chief Financial Officer | 0 | $0 | 3,000 (Direct) | View |
| 2021-02-09 Option Award | 2021-02-11 9:28 pm | N/A N/A | Axcella Health Inc. | AXLA | Chardonnet Laurent Chief Financial Officer | 205,000 | $0 | 211,266 (Direct) | View |
| 2020-10-30 Option Award | 2021-02-11 9:28 pm | N/A N/A | Axcella Health Inc. | AXLA | Chardonnet Laurent Chief Financial Officer | 2,601 | $3.6 | 211,266 (Direct) | View |
| 2019-12-18 Option Award | 2019-12-20 8:02 pm | N/A 2029-12-18 | Axcella Health Inc. | AXLA | Chardonnet Laurent Chief Financial Officer | 72,500 | $0 | 72,500 (Direct) | View |